Sains Malaysiana 44(5)(2015): 727–733

 

High Expression of Cyclooxygenase-2 in High Grade Human Prostate Adenocarcinoma

(Pengekspresan Tinggi Siklooksigenase-2 dalam Adenokarsinoma Prostat Manusia Gred Tinggi)

 

MOHD ROHAIZAD MD RODUAN¹*, NORHAFIZAH MOHTARRUDIN¹, CHONG PEI PEI²,

MALINA OSMAN³ & NORAINI MOHD DUSA⁴

 

¹Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia,

43400 Serdang, Selangor Darul Ehsan, Malaysia

 

²Department of Biomedical Sciences, Faculty of Medicine and Health Sciences,

Universiti Putra Malaysia, 43400 Serdang, Selangor Darul Ehsan, Malaysia

 

³Department of Medical Microbiology & Parasitology, Faculty of Medicine and Health Sciences,

Universiti Putra Malaysia, 43400 Serdang, Selangor Darul Ehsan, Malaysia

 

⁴Department of Pathology, Hospital Kuala Lumpur, Jalan Pahang, 50588 Kuala Lumpur

Malaysia

 

Received: 17 May 2013/Accepted: 22 December 2014

 

ABSTRACT

Inflammation plays an important role to the process of prostate carcinogenesis by increasing the rate of cell proliferation, which contributes to an aggressive tumour phenotype. Cyclooxygenase-2 (COX-2) has been found overexpressed in various types of cancer cells including prostate. The aim of this study was to investigate the COX-2 expressions in different types of human prostate tissues. Paraffin-embedded prostate tissues from 263 samples were examined for the expression of COX-2 marker by immunohistochemistry method. COX-2 was found highly expressed in prostate adenocarcinoma (p=0.001) as compared to benign and normal tissues. The score of COX-2 expressions in most of normal prostate was weak 49 (77.8%), while only 16 (16%) of BPH showed strong expression. 56 cases (56%) prostate cancer showed strong COX-2 expression. Prostate cancer cases showed significant differences in staining patterns as tumour grade increased. In addition, COX-2 expression was significantly correlated with Gleason score in cancerous tissues. This study suggests that COX-2 overexpression is associated with prostate cancer and higher grade tumour.

 

Keywords: Cyclooxygenase-2 (COX-2); immunohistochemistry; inflammations; overexpression; prostate adenocarcinoma

 

ABSTRAK

Inflamasi memainkan peranan penting dalam proses pembentukan kanser prostat melalui peningkatan kadar pembahagian sel. Inflamasi juga bertanggungjawab dalam pembentukan fenotip kanser prostat yang lebih agresif. Siklooksigenase-2 (COX-2 didapati diekspres lebih tinggi daripada aras biasa dalam pelbagai jenis sel kanser termasuk prostat. Tujuan kajian ini dijalankan adalah untuk mengkaji pengekspresan COX-2 dalam tisu prostat manusia yang berbeza. Sebanyak 263 tisu prostat tertanam parafin telah digunakan untuk mengkaji aras pengekspresan penanda COX-2 melalui kaedah imunohistokimia. Pengekspresan COX-2 didapati lebih tinggi dalam tisu adenokarsinoma prostat (p=0.001) berbanding tisu benigna dan tisu prostat yang normal. Kebanyakan tisu prostat normal mengekspres COX-2 yang lemah 49 (77.8%) dan hanya 16 (16%) tisu BPH menunjukkan pengekspresan COX-2 yang kuat. Manakala, 56 (56%) tisu kanser prostat menunjukkan pengekspresan COX-2 yang kuat. Tisu kanser prostat juga menunjukkan perbezaan corak perwarnaan COX-2 yang signifikan dengan peningkatan gred tumor. Selain itu, pengekspresan COX-2 menunjukkan perhubungan yang signifikan dengan skor Gleason dalam tisu kanser. Kajian ini mencadangkan bahawa terdapat hubungan antara pengekspresan COX-2 yang sangat tinggi dengan kanser prostat dan tumor gred tinggi.

 

Kata kunci: Adenikarsinoma prostat; siklooksigenase-2 (COX-2); imunohistokimia; inflamasi; pengekspresan

REFERENCES

Bosland, M.C., Oakley-Girvan, I. & Whittemore, A.S. 1999. Dietary fat, calories and prostate cancer risk. J. Natl. Cancer Inst. 91: 489-491.

Chan, G., Boyle, J.O., Yang, E.K., Zhang, F., Sacks, P.G., Shah, J.P., Edelstein, D., Soslow, R.A., Koki, A.T., Woerner, B.M., Masferrer, J.L. & Dannenberg, A.J. 1999. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 59: 991-994.

Chapple, K.S., Scott, N., Guillou, P.J., Coletta, P.L. & Hull, M.A. 2002. Interstitial cell cyclooxygenase-2 expression is associated with increased angiogenesis in human sporadic colorectal adenomas. J. Pathol. 198: 435-441.

Chu, J., Llyod, F.L., Trifan, O.C., Knapp, B. & Rizzo, M.T. 2003. Potential involvement of cyclooxygenase-2 pathway in the regulation of tumour associated angiogenesis and growth in pancreatic cancer. Mol. Cancer Ther. 2: 1-7.

Coussens, L.M. & Werb, Z. 2001. Inflammatory cells and cancer: Think different! J. Exp. Med. 193: F 23- 26.

Davies, G., Salter, J., Hills, M., Martin, L.A., Sacks, N. & Dowsett, M. 2003. Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. Clin. Cancer Res. 9: 2651-2656.

Fujiwaki, R., Iida, K., Kanasaki, H., Ozaki, T., Hata, K. & Miyazaki, K. 2002. Cyclooxygenase-2 expression in endometrial cancer: Correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase. Hum. Pathol. 33: 213-219.

Gottard, S. 1986. Relevance of fatty acids and eicosanoids to clinical and preventive medicine. Prog. Lipid Res. 25: 1-4.

Gupta, S., Srivastava, M., Ahmad, N., Bostwick, D.G. & Mukhtar, H. 2000. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate 42: 73-78.

Hao, Y., Gu, X., Zhao, Y., Stephen, G., Sha, W., Duane, T., Smoot, J.C., Wu, T.C. & Xiaowu, P. 2011. Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev. Res. 4(7): 1073- 1083.

Herschman, H.R. 1991. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60: 281-319.

Hla, T.A., Ristimaki & Sano, H. 1999. Role of the early gene Cyclooxygenase-2 (COX-2) in angiogenesis. Cancer Res. 59: 2223-2228.

Hwang, D., Scollard, D., Byrne, J. & Levine, E. 1998. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J. Natl. Cancer Inst. 90: 455-460.

Kakiuchi, Y., Tsujii, S., Tsujii, M., Murata, H., Kawai, N., Yasumaru, M., Kimura, A., Komori, M., Irie, T., Miyoshi, E., Sasaki, Y., Hayashi, N., Kawano, S. & Hori, M. 2002. Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res. 62: 1567-1572.

Kazuhiko, U., Ichikura, T., Mochizuki, H. & Shinomiya, N. 1998. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J. Surg. Oncol. 69: 168-172.

Koga, H., Sakisaka, S., Ohishi, M., Kawaguchi, T., Taniguchi, E., Sasatomi, K., Harada, M., Kusaba, T., Tanaka, M., Kimura, R., Nakashima, Y., Nakashima, O., Kojiro, M., Kurohiji, T. & Sata, M. 1999. Expression of cyclooxygenase-2 human hepatocellular carcinoma: Relevance to tumor dedifferentiation. Hepatology 29: 688-696.

Leung, W.K., To, K.F., Go, M.Y., Chan, K.K., Chan, F.K., Ng, E.K., Chung, S.C. & Sung, J.J. 2003. Cox-2 up-regulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma. Int. J. Oncol. 23: 1317-1322.

Liu, X.H., Kirschenbaum, A., Yao, S. & Levine, A.C. 1998. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res. 58: 4245-4249.

Liu, X.H., Kirschenbaum, A., Yao, S., Lee, R., Holland, J.F. & Levine, A.C. 2000. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J. Urol. 164: 820-825.

Madaan, S., Abel, P.D., Hewitt, R., Chaudhary, K.S., Stott, M.A., Stamp, G.W.H. & Lalani, E.N. 2000. Cytoplasmic induction and overexpression of cyclooxygenase-2 in human prostate cancer: Implications for prevention and treatment. Br. J. Urol. 86: 736-741.

Mostafa, M.K., Samira, A.M., Samia, M.G. & Moustafa, A.A.S. 2009. Cyclooxygenas-2 (COX-2) expression in Egyptian case of benign prostatic hyperplasia and prostatic adenocarcinoma. Acad. J. of Cancer Research 2: 33-39.

National Cancer Registry. 3rd ed. Ministry of Health, Malaysia. 2008. Cancer Incidence in Peninsular Malaysia 2003 – 2005. Kuala Lumpur: National Printers Malaysia.

O'Neill, G.P. & Ford-Hutchinson, A.W. 1993. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBBS Lett. 330: 156-160.

Oshima, M., Dinchuk, J.E., Kargman, S.L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J.M., Evans, J.F. & Taketo, M.M. 1996. Supression of intestinal polyposis in Apc?716 knockout mice by inhibition of Cyclooxgenase-2 (COX-2). Cell 87: 803-809.

Rahman, M., Selvarajan, K., Hasan, M.R., Chan, A.P., Jiri, C., Kim, J., Chen, S.K., Le, N.D., Kim, Y.B. & Tai, I.T. 2012. Inhibition of COX-2 in colon cancer modulates tumour growth and MDR-1 expression to enhance tumour regression in therapy-refractory cancers in vivo. Neoplasia 14(7): 624- 633.

Rahman, M.A., Dhar, D.K., Yamaguchi, E., Maruyama, S., Sato, T., Hayashi, H., Ono, T., Yamanoi, A., Kohno, H. & Nagasue, N. 2001. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: Possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin. Cancer Res. 7(5): 1325-1332.

Rodney, T.M. 2005. Immunohistochemical markers of prostate carcinoma, including prostate-specific membrane antigen (PSMA). ProPath. Sep 13: 1-2.

Shappell, S., Manning, S., Boeglin, W., Guan, Y., Roberts, R., Davis, L., Olson, S., Jack, G., Coeffy, C., Wheeler, T., Breyer, M. & Brash, A. 2001. Alteration in lipooxygenase and cyclooxygenase catalytic anctivity and mRNA expression in prostate carcinoma. Neoplasia 3: 287-303.

Sheng, H.J., Shao, M., Washington, M.K. & DubBois, R.N. 2001. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 276: 18075-18081.

Song, X.Q., Lin, H.P., Johnson, A.J., Tseng, P.H., Yang, Y.T., Kulp, S.K. & Chen, C.S. 2002. Cyclooxygenase-2 player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells. J. Natl. Cancer Inst. 94: 585-591.

Tsujii, M. & DuBois, R.N. 1995. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 83: 450-493.

Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M. & DuBois, R.N. 1998. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716.

Varma, M. & Jasani, B. 2005. Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer. Histopathology 47: 1-16.
Wang, W., Bergh, A. & Damber, J.E. 2005. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clin. Cancer Res. 11: 3250-3256.

Weitzman, S.A. & Gordon, L.I. 1993. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis. Blood 76: 655-663.
Wolff, H., Saukkonen, K., Anttila, S., Karjalainen, A., Vainio, H. & Ristimaki, A. 1998. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 58: 4997-5001.

Yoshimura, R., Sano, H., Masuda, C., Kawamura, M., Tsubouchi, Y., Chargui, J., Yoshimura, N., Hla, T. & Wada, S. 2000. Expression of cyclooxygenase-2in prostate carcinoma. Cancer 89: 589-596.

Zha, S., Gage, W., Sauvageot, J., Elizabeth, A., Mathew, J., Charles, M., Dennis, A., William, G., Angelo, M. & Charles, M. 2001. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostatic carcinoma. Cancer Res. 61: 8617-8623.

Zimmermann, K.C., Sarbia, M., Weber, A.A., Borchard, F., Gabbert, H.E. & Schrör, K. 1999. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 59: 198-204.

 

*Corresponding author; email: ijad_27@yahoo.com